Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

Share · JP3283730004 (XTKS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Chordia Therapeutics Inc.
No Price
Closing Price XTKS 28.04.2026: 155,00 JPY
28.04.2026 06:30
Current Prices from Chordia Therapeutics Inc.
ExchangeTickerCurrencyLast TradePriceDaily Change
XTKS: Tokyo
Tokyo
190A.T
JPY
28.04.2026 06:30
155,00 JPY
4,00 JPY
+2,65 %
Share Float & Liquidity
Free Float 27,91 %
Shares Float 19,86 M
Shares Outstanding 71,17 M
Company Profile for Chordia Therapeutics Inc. Share
Chordia is focused on the oncology area, with its target areas ranging from exploratory research to Proof of Concept (POC). For subsequent business development, we will build a system that allows us to make the best choices for maximizing corporate value, such as out-licensing and joint development and sales.

Company Data

Name Chordia Therapeutics Inc.
Company Chordia Therapeutics Inc.
Website https://www.chordiatherapeutics.com/en/index.html
Primary Exchange XTKS Tokyo
ISIN JP3283730004
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Hiroshi Miyake
Market Capitalization 11 Mrd.
Country Japan
Currency JPY
Employees 0,0 T
Address 26-1, Muraoka-Higashi 2-chome, Fujisawa, 251-0012 Fujisawa
IPO Date 2024-06-14

Ticker Symbols

Name Symbol
Tokyo 190A.T
More Shares
Investors who hold Chordia Therapeutics Inc. also have the following shares in their portfolio:
AMG Holdings Co.,Ltd.
AMG Holdings Co.,Ltd. Share
APRR 16/27
APRR 16/27 Bond